封面
市場調查報告書
商品編碼
1412679

吸入麻醉劑市場:按類型、最終用途分類 - 2024-2030 年全球預測

Inhalation Anesthetics Market by Type (Desfluran, Isoflurane, Sevoflurane), End Use (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年吸入麻醉劑市場規模為16.8億美元,預計2024年將達18.5億美元,2030年將達35.9億美元,複合年成長率為11.44%。

全球吸入麻醉劑市場

主要市場統計
基準年[2023] 16.8億美元
預測年份 [2024] 18.5億美元
預測年份 [2030] 35.9億美元
複合年成長率(%) 11.44%
吸入麻醉藥市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估吸入麻醉劑市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一種綜合工具,可以對吸入麻醉劑市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略,從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解:

1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。

3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1-吸入麻醉劑市場的市場規模與預測是多少?

2-在吸入麻醉劑市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?

3-吸入麻醉劑市場的技術趨勢和法律規範是什麼?

4-吸入麻醉劑市場主要供應商的市場佔有率為何?

5-進入吸入麻醉劑市場的適當型態和策略性手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 外科手術數量增加
      • 改善獲得醫療服務和手術的機會
    • 抑制因素
      • 減少與醫療保健相關的溫室氣體排放
    • 機會
      • 密集推出新型吸入麻醉解決方案
    • 任務
      • 吸入麻醉劑的副作用
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章吸入麻醉劑市場:依類型

  • DESFLURANE
  • Isoflurane
  • SEVOFLURANE

第7章吸入麻醉劑市場:依最終用途

  • 門診手術中心
  • 醫院

第8章美洲吸入麻醉劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太吸入麻醉劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲吸入麻醉劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析:按主要企業分類
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • AbbVie Inc.
    • Baxter International Inc.
    • Dechra Pharmaceuticals PLC
    • Eisai Co., Ltd.
    • Fresenius SE & Co. KGaA
    • Halocarbon Life Sciences, LLC
    • Hikma Pharmaceuticals PLC
    • Jiangsu Hengrui Medicine Co. Ltd.
    • Kent Scientific Corporation
    • Lunan Pharmaceutical Group Co. Ltd.
    • Midmark Corporation
    • Piramal Enterprises Limited
    • Raman & Weil Pvt. Ltd.
    • Sandoz International GmbH
    • Troikaa Pharmaceuticals Limited
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-742BD517FC6C

[194 Pages Report] The Inhalation Anesthetics Market size was estimated at USD 1.68 billion in 2023 and expected to reach USD 1.85 billion in 2024, at a CAGR 11.44% to reach USD 3.59 billion by 2030.

Global Inhalation Anesthetics Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.68 billion
Estimated Year [2024] USD 1.85 billion
Forecast Year [2030] USD 3.59 billion
CAGR (%) 11.44%
Inhalation Anesthetics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Inhalation Anesthetics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhalation Anesthetics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Inhalation Anesthetics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International Inc., Dechra Pharmaceuticals PLC, Eisai Co., Ltd., Fresenius SE & Co. KGaA, Halocarbon Life Sciences, LLC, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Kent Scientific Corporation, Lunan Pharmaceutical Group Co. Ltd., Midmark Corporation, Piramal Enterprises Limited, Raman & Weil Pvt. Ltd., Sandoz International GmbH, and Troikaa Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Inhalation Anesthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Desfluran
    • Isoflurane
    • Sevoflurane
  • End Use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Inhalation Anesthetics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhalation Anesthetics Market?

3. What are the technology trends and regulatory frameworks in the Inhalation Anesthetics Market?

4. What is the market share of the leading vendors in the Inhalation Anesthetics Market?

5. Which modes and strategic moves are suitable for entering the Inhalation Anesthetics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Inhalation Anesthetics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of surgical procedures
      • 5.1.1.2. Increasing Accessibility to Health Services and Surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Contributor to health care-related greenhouse gas emissions
    • 5.1.3. Opportunities
      • 5.1.3.1. Intense launch of the new inhalation anesthesia solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Side-effects of inhaler anesthesia drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Inhalation Anesthetics Market, by Type

  • 6.1. Introduction
  • 6.2. Desfluran
  • 6.3. Isoflurane
  • 6.4. Sevoflurane

7. Inhalation Anesthetics Market, by End Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Inhalation Anesthetics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Inhalation Anesthetics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Inhalation Anesthetics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AbbVie Inc.
    • 12.1.2. Baxter International Inc.
    • 12.1.3. Dechra Pharmaceuticals PLC
    • 12.1.4. Eisai Co., Ltd.
    • 12.1.5. Fresenius SE & Co. KGaA
    • 12.1.6. Halocarbon Life Sciences, LLC
    • 12.1.7. Hikma Pharmaceuticals PLC
    • 12.1.8. Jiangsu Hengrui Medicine Co. Ltd.
    • 12.1.9. Kent Scientific Corporation
    • 12.1.10. Lunan Pharmaceutical Group Co. Ltd.
    • 12.1.11. Midmark Corporation
    • 12.1.12. Piramal Enterprises Limited
    • 12.1.13. Raman & Weil Pvt. Ltd.
    • 12.1.14. Sandoz International GmbH
    • 12.1.15. Troikaa Pharmaceuticals Limited
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INHALATION ANESTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALATION ANESTHETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INHALATION ANESTHETICS MARKET DYNAMICS
  • FIGURE 7. INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 10. INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INHALATION ANESTHETICS MARKET SIZE, BY DESFLURAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 10. INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. INHALATION ANESTHETICS MARKET LICENSE & PRICING